Linked Life Data

19169683

Source:http://linkedlifedata.com/resource/pubmed/id/19169683

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2009-7-29
pubmed:abstractText
To evaluate the response to lapatinib, an inhibitor of epidermal growth factor receptors 1 and 2, in patients with advanced bilary tree cancer (BTC) and hepatocellular cancer (HCC).
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1432-0843
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
64
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
777-83
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer.
pubmed:affiliation
University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. rramanathan@tgen.org
pubmed:publicationType
Journal Article, Clinical Trial, Phase II, Research Support, N.I.H., Extramural